Influenza Viral Challenge Study of CC-42344 in Healthy Participants
Study sponsor: Cocrystal Pharma, Inc. · COCP
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-05-03Actual
Enrollment · participants78Actual
Source updated2025-08-05Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.